Carregant...
Nutlin-3 enhances the bortezomib sensitivity of p53-defective cancer cells by inducing paraptosis
The proteasome inhibitor, bortezomib, is ineffective against many solid tumors. Nutlin-3 is a potent antagonist of human homolog of murine double minute 2/p53 interaction exhibiting promising therapeutic anti-cancer activity. In this study, we show that treatment of various p53-defective bortezomib-...
Guardat en:
| Publicat a: | Exp Mol Med |
|---|---|
| Autors principals: | , , , , |
| Format: | Artigo |
| Idioma: | Inglês |
| Publicat: |
Nature Publishing Group
2017
|
| Matèries: | |
| Accés en línia: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5579507/ https://ncbi.nlm.nih.gov/pubmed/28798402 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/emm.2017.112 |
| Etiquetes: |
Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!
|